Exodus Point Capital Management, LP Humacyte, Inc. Transaction History
Exodus Point Capital Management, LP
- $13.1 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding HUMA
# of Institutions
102Shares Held
23.1MCall Options Held
67.8KPut Options Held
198K-
Black Rock Inc. New York, NY4.79MShares$27.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.02MShares$23 Million0.0% of portfolio
-
Aigh Capital Management LLC Baltimore, MD2.16MShares$12.3 Million2.7% of portfolio
-
Sio Capital Management, LLC New York, NY2MShares$11.4 Million2.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.35MShares$7.73 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $589M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...